We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
-16.78%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$25.5B
AUM Growth
-$11.1B
Cap. Flow
-$5.25B
Cap. Flow %
-20.57%
Top 10 Hldgs %
6.83%
Holding
3,851
New
730
Increased
952
Reduced
1,216
Closed
943

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.44%
2 Technology 14.21%
3 Industrials 12.1%
4 Healthcare 9.72%
5 Financials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPRO icon
2851
PUT
GoPro
GPRO
$133M
$65K ﹤0.01%
15,400
+300
+2% +$1.68K
CRVO icon
2852
CervoMed
CRVO
$24.1M
$64K ﹤0.01%
+429
New +$146K
ICL icon
2853
ICL Group
ICL
$6.65B
$63K ﹤0.01%
11,109
-16,919
-60% -$100K
AVH
2854
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$63K ﹤0.01%
+15,450
New +$78.2K
ADIL
2855
Adial Pharmaceuticals
ADIL
$8.32M
$60K ﹤0.01%
+19
New +$30.4K
DRRX
2856
DELISTED
DURECT Corp
DRRX
$60K ﹤0.01%
12,411
+669
+6% +$5.84K
SNDX icon
2857
Syndax Pharmaceuticals
SNDX
$1.69B
$60K ﹤0.01%
13,487
-9,578
-42% -$52.5K
WPRT
2858
Westport Fuel Systems
WPRT
$33.4M
$59K ﹤0.01%
+4,427
New +$100K
XIN
2859
DELISTED
Xinyuan Real Estate
XIN
$59K ﹤0.01%
+1,550
New +$63.4K
HNRG icon
2860
Hallador Energy
HNRG
$704M
$54K ﹤0.01%
10,661
-17,700
-62% -$104K
ATYR
2861
aTyr Pharma
ATYR
$48.2M
$54K ﹤0.01%
7,728
+315
+4% +$2.64K
CERS icon
2862
Cerus
CERS
$441M
$52K ﹤0.01%
10,354
-295,051
-97% -$1.71M
CFMS
2863
DELISTED
Conformis, Inc. Common Stock
CFMS
$52K ﹤0.01%
5,857
-4,526
-44% -$76.1K
CSLT
2864
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$51K ﹤0.01%
+23,683
New +$58.8K
ASYS icon
2865
Amtech Systems
ASYS
$305M
$50K ﹤0.01%
+11,100
New +$54.2K
XFOR icon
2866
X4 Pharmaceuticals
XFOR
$386M
$50K ﹤0.01%
119
-79
-40% -$30.1K
AAC
2867
DELISTED
AAC Holdings
AAC
$49K ﹤0.01%
+34,819
New +$140K
FLNT
2868
Fluent
FLNT
$104M
$48K ﹤0.01%
+2,235
New +$40.7K
RESN
2869
DELISTED
Resonant Inc.
RESN
$48K ﹤0.01%
+35,759
New +$87.3K
TRIB
2870
Trinity Biotech
TRIB
$7.51M
$44K ﹤0.01%
128
-34
-21% -$15.7K
OBE
2871
Obsidian Energy
OBE
$678M
$41K ﹤0.01%
14,522
-5,616
-28% -$24.9K
TRVN
2872
DELISTED
Trevena, Inc.
TRVN
$41K ﹤0.01%
154
-407
-73% -$230K
LLEX
2873
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$40K ﹤0.01%
+29,058
New +$78.7K
IMUX icon
2874
Immunic
IMUX
$192M
$39K ﹤0.01%
522
+156
+43% +$18.3K
FRTX
2875
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$36K ﹤0.01%
98
-34
-26% -$13.3K

Similar funds

Two Sigma Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Two Sigma Investments held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Two Sigma Investments withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Two Sigma Investments opened a new position in Starbucks worth $176M.

  • Two Sigma Investments's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
  • Two Sigma Investments added most to SLB Ltd in Q4 2018, an estimated $230M increase.
  • Two Sigma Investments's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
  • Two Sigma Investments fully exited Elevance Health in Q4 2018, selling an estimated $180M.
  • Two Sigma Investments's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
  • Two Sigma Investments opened 730 new positions and closed 943 in Q4 2018.
  • Two Sigma Investments's portfolio value fell 30% quarter-over-quarter to $25.5B.

Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.